TrialCardiovascular diabetology2013

Treatment of patients with type 2 diabetes with exenatide once weekly versus oral glucose-lowering medications or insulin glargine: achievement of glycemic and cardiovascular goals.

Alison R Meloni et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.